Nesbitt A

ORCID: 0000-0001-5243-4343 · 1 paper in corpus
2017
A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial.
Human reproduction (Oxford, England) ·doi:10.1093/humrep/dex253

Study questionCan increasing the duration of LH-exposure with a second dose of kisspeptin-54 improve oocyte maturation in women at high risk of ovarian hyperstimulation syndrome (OHSS)?Summary answerA second dose of kisspeptin-54 at 10 h fo…